Sano et al developed a model for identifying a patient with Kawasaki Disease who is likely to be unresponsive to intravenous immunoglobulin (IVIG) therapy. A patient unresponsive to IVIG may benefit from more aggressive management. The authors are from multiple hospitals in Japan.